Ye Tian

Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial

Yu‐Pei Chen, Xu Liu, Qin Zhou et al. · The Lancet · 2021 · 234 citations

Medicine, Oncology, Pharmacology +12

A genome-wide association study identifies six novel risk loci for primary biliary cholangitis

Fang Qiu, Ruqi Tang, Xianbo Zuo et al. · Nature Communications · 2017 · 149 citations · Full text

Life Sciences, Genetics, Immunology +15

Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial

Arlene O. Siefker‐Radtke, Nobuaki Matsubara, S.H. Park et al. · Annals of Oncology · 2023 · 80 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

MicroRNA-101 down-regulates sphingosine kinase 1 in colorectal cancer cells

Min‐Bin Chen, Lan Yang, Pei‐Hua Lu et al. · Biochemical and Biophysical Research Communications · 2015 · 71 citations

Life Sciences, Molecular Biology, Oncology +14

MiR-216b increases cisplatin sensitivity in ovarian cancer cells by targeting PARP1

Y Liu, Xueyan Lin, Ye Tian · Cancer Gene Therapy · 2017 · 61 citations

Medicine, Molecular Biology, Oncology +14